These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 14747958)

  • 1. Radionuclide therapy.
    Bomanji JB
    Clin Med (Lond); 2006; 6(3):249-53. PubMed ID: 16826856
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective Effect of Alpha-Lipoic Acid on Salivary Dysfunction in a Mouse Model of Radioiodine Therapy-Induced Sialoadenitis.
    Jung JH; Kim JH; Jung MH; Kim SW; Jeong BK; Woo SH
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the physical and biological dosimetry methods in iodine-131-treated patients.
    Ozdal A; Erselcan T; Özdemir Ö; Özgüven Y; Silov G; Erdoğan Z
    World J Nucl Med; 2018; 17(4):253-260. PubMed ID: 30505223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.
    Molenaar RJ; Pleyer C; Radivoyevitch T; Sidana S; Godley A; Advani AS; Gerds AT; Carraway HE; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Angelini D; Maciejewski JP; Majhail N; Sekeres MA; Mukherjee S
    Leukemia; 2018 Apr; 32(4):952-959. PubMed ID: 29104287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronucleus frequencies in groups receiving external or internal radiation.
    Özdal A; Erselcan T; Özdemir Ö; Silov G; Erdoğan Z; Turhal Ö
    Indian J Nucl Med; 2016; 31(3):179-84. PubMed ID: 27385886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and dosimetric effects of (131)I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments.
    da Silva MA; Valgôde FG; Gonzalez JA; Yoriyaz H; Guimarães MI; Ribela MT; Buchpiguel CA; Bartolini P; Okazaki K
    Radiat Environ Biophys; 2016 Aug; 55(3):317-28. PubMed ID: 27013085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Response of Positron Emission Tomography Scan Exposure and Adaptive Response in Humans.
    Schnarr K; Carter TF; Gillis D; Webber C; Lemon JA; Dayes I; Dolling JA; Gulenchyn K; Boreham DR
    Dose Response; 2015; 13(4):1559325815611904. PubMed ID: 26740810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients.
    Monzen S; Mariya Y; Wojcik A; Kawamura C; Nakamura A; Chiba M; Hosoda M; Takai Y
    Mol Clin Oncol; 2015 May; 3(3):692-698. PubMed ID: 26137289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic oxidative stress to nucleic acids is unaltered following radioiodine therapy of patients with benign nodular goiter.
    Bonnema SJ; Stovgaard ES; Fast S; Broedbaek K; Andersen JT; Weimann A; Grupe P; Hegedüs L; Poulsen HE
    Eur Thyroid J; 2015 Mar; 4(1):20-5. PubMed ID: 25960958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the radioprotective effect of turmeric extract and vitamin E in mice exposed to therapeutic dose of radioiodine.
    Bhartiya US; Raut YS; Joseph LJ; Hawaldar RW; Rao BS
    Indian J Clin Biochem; 2008 Oct; 23(4):382-6. PubMed ID: 23105792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the cytogenetic effects of (131)I preceded by recombinant human thyrotropin (rhTSH) in peripheral lymphocytes of Wistar rats.
    da Silva MA; Calil Cury Guimarães MI; Yoriyaz H; Carvalho Pinto Ribela MT; Buchpiguel CA; Bartolini P; Okazaki K
    Radiat Environ Biophys; 2008 Nov; 47(4):453-61. PubMed ID: 18712404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis.
    Federico G; Boni G; Fabiani B; Fiore L; Lazzeri P; Massart F; Traino C; Verola C; Saggese G; Mariani G; Scarpato R
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2113-21. PubMed ID: 18648806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
    Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
    Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
    Eberlein U; Scherthan H; Bluemel C; Peper M; Lapa C; Buck AK; Port M; Lassmann M
    J Nucl Med; 2016 Feb; 57(2):173-9. PubMed ID: 26564321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
    De Klerk JM; Oyen WJ
    Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship.
    Erselcan T; Sungu S; Ozdemir S; Turgut B; Dogan D; Ozdemir O
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):676-84. PubMed ID: 14747958
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.